Package Leaflets (PL) for Human medicinal products

The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.

The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.

The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Product Information Leaflets 61 - 90 of 143
<  Previous 30    |  1  2  3  4  5  |  Next 30   >
SPC	Status for supply	Name of the medicinal product
		European Medicines Agency's website: Zokinvy - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Zoladex 10.8 mg implantaatti PL 2024-01-12
SPC	Resepti	Zoladex 3.6 mg implantaatti PL 2024-01-12
		European Medicines Agency's website: Zoledronic Acid Accord - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Zoledronic Acid Fresenius Kabi 4mg-5ml infuusiokonsentraatti liuosta varten PL 2017-09-27
		European Medicines Agency's website: Zoledronic acid Mylan - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Zoledronic Acid Oresund Pharma 4 mg-100 ml infuusioneste, liuos PL 2024-04-24
SPC	Resepti	Zoledronic Acid Oresund Pharma 5 mg-100 ml infuusioneste, liuos PL 2024-04-24
SPC	Resepti	Zoledronic acid Sandoz 4 mg - 100 ml infuusioneste, liuos PL 2020-10-27
SPC	Resepti	Zoledronic acid Sandoz 4 mg - 5 ml infuusiokonsentraatti, liuosta varten PL 2020-10-27
SPC	Resepti	Zoledronic acid Stada 4 mg-100 ml infuusioneste liuos PL 2020-04-21
SPC	Resepti	Zoledronic acid Sun 5 mg infuusioneste, liuos PL 2021-06-03
SPC	Resepti	Zoledronic acid SUN Pharma 5 mg-100ml infuusioneste, liuos PL 2024-07-27
		European Medicines Agency's website: Zoledronic acid Teva - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Zolestad 5 mg - 100 ml infuusioneste, liuos PL 2022-08-15
		European Medicines Agency's website: Zolgensma - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Zolmistad 2,5 mg tabletti, suussa hajoava PL 2023-07-12
SPC	Resepti	Zolmitriptan Sandoz 2.5 mg tabletti, suussa hajoava PL 2021-06-03
SPC	Resepti	Zolmitriptan stada 2,5 mg, tabletti PL 2023-07-12.doc
SPC	Resepti	Zoloft 50 mg, 100 mg tabletti, kalvopäällysteinen PL 2024-06-19
SPC	Resepti	Zolpidem Vitabalans 10 mg tabletti, kalvopäällysteinen PL 2023-10-12.docx
		European Medicines Agency's website: ZOLSKETIL pegylated liposomal - EMA: EPAR PI Finnish Swedish
SPC	Itsehoito	Zolt 15 mg enterokapseli, kova PL OTC 2023-09-11
SPC	Resepti	Zolt 15 mg, 30 mg enterokapseli, kova PL Rx 2023-09-11
SPC	Resepti	Zomacton 10 mg injektiokuiva-aine ja liuotin PL 2021-06-15
		European Medicines Agency's website: Zomarist - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Zometa - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Zomig 2.5 mg, 5 mg tabletti, kalvopäällysteinen PL 2022-01-11
SPC	Resepti	Zomig Nasal 2.5 mg-annos, 5 mg-annos nenäsumute PL 2023-02-21
SPC	Resepti	Zomig Rapimelt 2,5 mg, 5 mg tabletti, suussa hajoava PL 2024-06-14
<  Previous 30    |  1  2  3  4  5  |  Next 30   >